Skip to main content
Malaysian Family Physician : the Official Journal of the Academy of Family Physicians of Malaysia logoLink to Malaysian Family Physician : the Official Journal of the Academy of Family Physicians of Malaysia
. 2015 Aug 31;10(2):9–21.

Depression, anxiety and stress among patients with diabetes in primary care: A cross-sectional study

KC Tan 1, GC Chan 2, H Eric 3, AI Maria 4, MJ Norliza 5, BH Oun 6, MT Sheerine 7, SJ Wong 8, SM Liew 9
PMCID: PMC4826577  PMID: 27099657

Abstract

Background

The incidence of diabetes mellitus is ever increasing. Individuals with diabetes mellitus may have concurrent mental health disorders and are shown to have poorer disease outcomes. The objectives of this study were to determine the prevalence of depression, anxiety and stress (DAS) in diabetes patients aged 20 years or more in the primary care setting.

Methods

This was a cross-sectional study involving the use of self-administered questionnaire conducted in eight primary care private and government clinics in Pulau Pinang and Melaka, Malaysia. The validated DASS-21 questionnaire was used as a screening tool for the symptoms of DAS. Prior permission was obtained from the patients and, clearance from ethical committee was obtained before the start of the study. Data analysis was done using SPSS statistical software.

Results

A total of 320 patients with diabetes from eight centres were enrolled via convenience sampling. Sample size was calculated using the Kish’s formula. The prevalence of DAS among patients with diabetes from our study was 26.6%, 40% and 19.4%, respectively. Depression was found to be significantly associated with marital status and family history of DAS; anxiety was significantly associated with monthly household income, presence of co-morbidities and family history of DAS; and stress was significantly associated with occupation and family history of DAS.

Conclusion

The prevalence of DAS was higher in patients with diabetes compared with the general community. We recommend to routinely screen all patients with diabetes using the DASS-21 questionnaire because it is easy to perform and inexpensive.

Background

Diabetes is a common chronic disease worldwide. Its prevalence is increasing and expected to be 366 million by the year 2030.1 According to the Malaysian National Health and Morbidity Survey III (NHMS), the prevalence of diabetes mellitus among individuals aged 18 years or more has increased from 11.6% in 2006 to 15.2% in 2011.2 It is well recognised that many individuals with chronic illnesses also have co-morbid unrecognised mental health disorders.3 Detecting depression in a diabetic patient has important significance with regard to mortality, as there was a 54% greater mortality in patients with diabetics and depression than the non-diabetic ones.4 The International Diabetes Federation has stressed the importance of integrating psychological care in the management of diabetes.5

Depression is a common mental disorder, characterised by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness and poor concentration. It can be long-lasting or recurrent, substantially impairing a person’s ability to function at work or school, or cope with daily life.6

Anxiety is defined as a feeling of worry, nervousness or unease about something with an uncertain outcome; whereas stress is a state of mental or emotional strain or tension resulting from adverse or demanding circumstances.7

Various studies have been done to determine the prevalence of depression, anxiety and stress (DAS) in patients with diabetes. Those with depression and diabetes have been shown to have poorer outcomes in the disease management.8 This not only poses a great burden to the healthcare service and expenditure but also directly affects quality of life of patients.

In Malaysia, there is a paucity of studies done on the prevalence of DAS among patients with diabetes presenting to the primary care clinics and regarding the various socio-demographic factors associated with it.

This study was carried out with the aim to determine the prevalence of DAS in patients with type 2 diabetes mellitus aged 20 years or more in primary care clinic settings, and to determine any association between DAS and patients’ sociodemographic factors.

Methods

Study design

This was a cross-sectional study involving the use of a self-administered questionnaire that was conducted from January to June, 2014.

Study setting

This multi-centred study was conducted in a few selected clinics both in Penang and Melaka states of Malaysia. The centres consisted of both government and private primary care clinics.

Study population

Adult patients aged more than 20 years who were diagnosed with type 2 diabetes mellitus under follow-up of the respective clinics were included in the study.

Patients with cognitive impairment, endstage renal failure, cancers and any major lifethreatening diseases were excluded from the study.

Sampling and sample size

A total of 320 patients or 40 patients from each of the eight centres were obtained by means of convenience sampling. The minimum number of samples needed for the study was calculated using the Kish’s formula:

Sample size = z2 (p (1-p)/c2)

Where z = 1.96 for 95% confidence interval (CI)

p = prevalence (of depression for diabetes mellitus based on Roshana study13: 20.8%), and

c = desired level of precision.

Data collection tools and measurements

A self-administered multi-language questionnaire consisting of three sections, (i) socio-demographic information (ii) severity of diabetes mellitus and (iii) detection of DAS, was given to the patients during clinic registration.

The socio-demographic data of the patients were recorded, including age, sex, ethnicity, religion, marital status, education level, occupations and household income. Factors that may affect the severity of diabetes mellitus were also recorded, such as smoking status, HbA1c level, duration of diabetes mellitus, presence of co-morbidities, complications and family history of diabetes mellitus.

The section on the detection of DAS was done using validated DASS-21 questionnaire. It is a set of three self-reported scales designed to measure the negative emotional states of DAS. The DASS-21 questionnaire has 21 items, assessing the symptoms of depression, anxiety and stress respectively. The patients were asked to rate their experience on each symptom on a 4-point severity scale ranging from ‛0’ (does not apply to me), to ‛3’ (applies to me most of the time). The DASS-21 questionnaire has been translated into multiple languages including Mandarin and Malay, which has been validated for its use.9

Scores of each scale were later summed up and categorised as normal, mild, moderate, severe and extremely severe according to the DASS manual.

Data collection procedure

Patients were screened for study eligibility by trained clinic staff on registration to see the doctor. They were given the patient information sheet, which was made available in multiple languages. Patients who agreed for the study were given the questionnaire to fill up while awaiting their turn to be seen by the doctor.

While inside the consultation room with the doctor, the questionnaire was checked for completion by the doctor. If needed, further details and explanation were given by the doctor. The section concerning the severity of the diabetes mellitus was completed by the doctor.

Data management and analysis

All questionnaires were checked for completeness and entered manually using SPSS statistical software version 20. All the continuous variables were expressed as mean and standard deviation. Frequencies and percentages for categorical variables were calculated. Pearson chi-square test was used to measure the association between the variables in the study. Predictors for outcomes were identified. Significant associations were defined as those with a p-value <0.05.

Application for ethical committee

The study had obtained ethical approval from both the Medical Ethics Committee of University Malaya Medical Centre and the Medical Review & Ethics Committee (MREC), Ministry of Health Malaysia.

Results

A total of 320 patients from eight centres involving government and private primarycare clinics were successfully recruited for the survey.

Socio-demographic, clinical and other characteristics of the subjects

The demographic characteristics of the study population are shown in Table 1. The mean age of the patients was 57.1 ± 10.84 years. Majority of the respondents were 50–59 years old (35.0%), women (53.1%), Malays (49.4%) and married (77.8%). Almost 90% of the respondents had received some kind of formal education, and 13.1% of them had completed university or college education. Approximately 45% of respondents were employed and 34% of the respondents had monthly household income of more than RM 2000.

Table 1: Frequency distribution of respondents by socio-demographic characteristics and selected variables.

Demographic characteristics (n = 320) Mean SD n Percentage
Age (years)
<29 5.71 10.84 6 1.9
30–59 173 54.0
=80 141 441
Sex
Male 150 46.9
Female 170 53.1
Ethnicity
Malay 158 49.4
Chinese 111 34.7
Indian 46 14.4
Others 5 1.6
Religion
Islam 158 49.4
Buddhist 100 31.3
Christian 28 8.8
Hindu 30 9.4
Others 4 1.3
Martial Status
Single 34 10.6
Married 249 77.8
Separated 12 3.8
Widow(er) 25 7.8
Education level
No formal education 33 10.3
Primary school 90 28.1
Secondary school 155 48.4
University/college 42 13.1
Occupation
Professional 33 10.3
Non-professional 115 35.9
Unemployed 110 35.4
Retired 62 19.4
Household income (RM)
<1000 118 36.9
1001–2000 93 29.1
>2001 109 34.1
Smoking
Smokers 61 19.1
Non-smokers 259 18.9
HbA1c (%)
≤6.5 7.78 1.697 67 20.9
>6.5 253 79.1
Duration of diabetes (years)
≤1 5.41 5.02 61 19.1
1–4.99 133 41.6
5.0–9.99 90 28.1
10.0–14.99 19 5.9
15.0–19.99 10 3.1
>20 7 2.2
Co-morbidity
Yes 365 25.3
No 55 17.2
Compilation
Yes 81 25.3
No 239 74.7
Family history of DAS
Yes 16 5.0
No 304 95

The mean duration of diabetes mellitus was 5.41 ± 5.02 years and more than one-third (39.3%) of the respondents had been diagnosed with diabetes mellitus for more than 5 years. Approximately 80% of the respondents had HbA1c levels of more than 6.5%. The mean HbA1c level of the whole study population was 7.78 %± 1.7%. More than 80% of the respondents had at least one or more concurrent co-morbidities. One-quarter of the population had a known diabetic complication. Hypertension (68.1%) and dyslipidaemia (65.9%) were the top two co-morbidities in the study population.

Majority of the patients received only oral medication (74.4%) whereas 15% received a combination of both oral medication and insulin. Only one subject was on insulin alone (0.3%). For follow-up of their conditions, the majority (60.9%) consulted their doctors once every 3 months or more.

Association between depression and sociodemographic variables

Table 2 shows the association between depression and socio-demographic variables of the subjects. On analysis using Pearson chi-square test, depression was found to be significantly associated with marital status and family history of DAS. Subjects who were married were less likely to be depressed (81.7%, p = 0.031). Family history of DAS was found to be strongly associated with depression (15.3%; p<0.01).

Table 2: Association between depression status and socio-demographic and clinical characteristic.

Variable Depression symptom
Yes (n = 85) Percentage No (n = 235) Percentage p-value
Age (years)
Mean 56.13 57.45 0.338
Sex
Male 33 (22.0) 117 (78.0) 0.083
Female 52 (30.6) 118 (69.4)
Ethnicity
Malay 34 (21.5) 124 (78.5) 0.183
Chinese 32 (28.8) 79 (71.2)
Indian 18 (39.1) 28 (60.9)
Others 1 (20.0) 4 (80.0)
Religion
Islam 35 (22.2) 123 (77.8) 0.297
Buddhist 28 (28.0) 72 (72.0)
Christian 9 (32.1) 19 (67.9)
Hindu 12 (40.0) 18 (60.0)
Others 1 (25.0) 3 (75.0)
Marital status
Single 15 (44.1) 19 (55.9) 0.031
Married 57 (22.9) 192 (77.1)
Separated 5 (41.7) 7 (58.3)
Widow(er) 8 (32.0) 17 (68.0)
Education level
No formal education 7 (21.2) 26 (78.8) 0.385
Primary school 19 (21.1) 71 (78.9)
Secondary school 46 (29.7) 109 (70.3)
University/college 13 (40.0) 29 (69.0)
Occupation
Professional 9 (27.3) 24 (72.7) 0.129
Non-professional 39 (33.9) 76 (66.1)
Unemployed 25 (22.7) 85 (77.3)
Retired 12 (19.4) 50 (80.6)
Household income (RM)
<1000 32 (27.1) 86 (72.9) 0.334
1001–2000 29 (31.2) 64 (68.8)
>2001 24 (22.0) 85 (78.0)
Smoking
Smokers 15 (24.6) 46 (75.4) 0.698
Non smokers 70 (27.0) 189 (73.0)
HbA1c (%)
Mean 7.7 7.8 0.624
Duration of diabetes (months)
Mean 59.55 66.88 0.338
Duration of follow-up
2 weeks 3 (42.9) 4 (57.1) 0.890
1 month 24 (25.0) 72 (75.0)
2 months 6 (27.3) 16 (72.7)
3 months 22 (27.5) 58 (72.5)
5 months 30 (19.1) 85 (80.9)
Diabetic treatment
Lifestyle modification 11 (32.4) 23 (67.6) 0.568
Oral medication 59 (24.8) 179 (75.2)
Oral and insulin 15 (31.9) 32 (68.1)
Insulin only 0 (0) 1 (100.0)
Co-morbidity
Yes 69 (26.0) 196 (74.0) 0.641
No 16 (29.1) 39 (70.9)
Complication
Yes 25 (30.9) 56 (69.1) 0.31
No 60 (25.1) 179 (74.9)
Family history of DAS
Yes 13 (81.3) 3 (18.8) <0.001
No 72 (23.7) 232 (76.3)

Association between anxiety and sociodemographic variables

Table 3 shows the association between anxiety and socio-demographic variables of the subjects. Monthly household income (MHI), presence of co-morbidities and family history of DAS were found to be significantly associated with anxiety. Subjects with higher MHI (>RM 2001) appeared to have less anxiety (39.6%; p = 0.033). Of those with concomitant co-morbidities, 88.3% of the respondents also scored positive for anxiety (p = 0.034). Family history of DAS was found to be strongly associated with anxiety at (10.2%; p<0.001).

Table 3: Association between anxiety status and socio-demographic and clinical characteristic.

Variable Anxiety symptom
Yes (n =128) Percentage No (n = 192) Percentage p-value
Age (years)
Mean 57.27 59.68 0.812
Sex
Male 52 (34.7) 98 (65.3) 0.067
Female 76 (44.7) 94 (55.3)
Ethnicity
Malay 68 (43.0) 90 (57.0) 0.429
Chinese 39 (43.0) 72 (64.9)
Indian 20 (35.1) 26 (56.5)
Others 1 (43.5) 4 (80.0)
Religion
Islam 67 (20.0) 91 (57.6) 0.469
Buddhist 35 (42.4) 65 (65.0)
Christian 9 (35.0) 19 (67.9)
Hindu 15 (32.1) 15 (50.0)
Others 2 (50.0) 2 (50.0)
Marital status
Single 15 (50.0) 19 (38.2) 0.031
Married 94 (61.8) 155 (62.2)
Separated 4 (37.8) 8 (66.7)
Widow(er) 9 (33.3) 16 (64.0)
Education level
No formal education 17 (36.0) 16 (48.5) 0.404
Primary school 34 (51.5) 56 (62.2)
Secondary school 58 (37.8) 97 (62.6)
University/college 19 (37.4) 23 (54.8)
Occupation
Professional 10 (45.2) 23 (69.7) 0.446
Non-professional 47 (30.3) 68 (59.1)
Unemployed 42 (40.9) 68 (61.8)
Retired 29 (38.2) 33 (53.2)
Household income (RM)
<1000 55 (46.8) 63 (53.4) 0.033
1001–2000 40 (46.6) 53 (57.0)
>2001 33 (43.0) 76 (69.7)
Smoking
Smokers 27 (30.3) 34 (55.7) 0.45
Non smokers 101 (44.3) 158 (61.0)
HbA1c (%)
Mean 7.75 (39.0) 7.79 0.843
Duration of diabetes (months)
Mean 62.67 (28.6) 66.44 0.584
Duration of follow-up
2 weeks 2 (40.6) 5 (71.4) 0.436
1 month 39 (54.5) 57 (59.4)
2 months 12 (33.8) 10 (45.5)
3 months 27 (41.7) 53 (66.3)
5 months 48 (38.2) 67 (58.3)
Diabetic treatment
Lifestyle modification 13 (39.1) 21 (61.8) 0.636
Oral medication 93 (46.8) 145 (60.9)
Oral and insulin 22 (0) 25 (53.2)
Insulin only 0 1 (100.0)
Co-morbidity
Yes 113 (42.6) 152 (57.4) 0.034
No 15 (27.3) 40 (72.7)
Complication
Yes 36 (44.4) 45 (55.6) 0.345
No 92 (38.5) 147 (61.5)
Family history of DAS
Yes 13 (81.3) 3 (18.8) 0.001
No 115 (37.8) 189 (62.2)

Association of stress with socio-demographic variables

Table 4 shows the association of stress with socio-demographic data of the subjects. Stress was found to be significantly associated with occupation and family history of DAS. Nonprofessional group had higher stress level at (51.6%; p = 0.026). Family history of DAS was again found to be strongly associated with stress at (22.6%; p <0.001). A summary of the associations of DAS with the demographic variables and the selected ones is presented in Table

Table 4: Association between anxiety status and socio-demographic characteristic and other selected variable.

Variable Stress symptom
Yes (n =62) Percentage No (n = 258) Percentage p-value
Age (years)
Mean 55.53 57.47 0.206
Sex
Male 25 (16.7) 125 (83.3) 0.25
Female 37 (21.8) 133 (78.2)
Ethnicity
Malay 28 (17.7) 130 (82.3) 0.072
Chinese 19 (17.1) 92 (82.9)
Indian 15 (32.6) 31 (67.4)
Others 0 (0) 5 (100.0)
Religion
Islam 28 (17.7) 130 (82.3) 0.206
Buddhist 42 (17.0) 207 (83.0)
Christian 7 (25.0) 21 (75.0)
Hindu 10 (33.3) 20 (66.7)
Others 0 (0) 4 (100.0)
Marital status
Single 12 (35.3) 22 (64.7) 0.08
Married 42 (16.9) 207 (83.1)
Separated 3 (25.0) 9 (75.0)
Widow(er) 5 (20.0) 20 (80.0)
Education level
No formal education 7 (21.2) 26 (78.8) 0.495
Primary school 18 (20.0) 72 (80.0)
Secondary school 28 (18.1) 127 (81.9)
University/college 9 (21.4) 33 (78.6)
Occupation
Professional 4 (12.1) 29 (87.9) 0.026
Non-professional 32 (27.8) 83 (72.2)
Unemployed 19 (17.3) 91 (82.7)
Retired 7 (11.3) 55 (88.7)
Household income (RM)
<1000 27 (22.9) 91 (77.1) 0.053
1001–2000 22 (23.7) 71 (76.3)
>2001 13 (11.9) 96 (88.1)
Smoking
Smokers 15 (24.6) 46 (75.4) 0.252
Non smokers 70 (27.0) 189 (73.0)
HbA1c (%)
Mean 7.7 7.8 0.757
Duration of diabetes (months)
Mean 59.6 66.22 0.438
Duration of follow-up
2 weeks 3 (42.9) 4 (57.1) 0.430
1 month 21 (21.9) 75 (78.1)
2 months 3 (13.6) 19 (86.4)
3 months 13 (16.3) 67 (83.8)
5 months 22 (19.1) 93 (80.9)
Diabetic treatment
Lifestyle modification 10 (29.4) 24 (70.6) 0.058
Oral medication 38 (16.0) 200 (84.0)
Oral and insulin 14 (29.8) 33 (70.2)
Insulin only 0 (0) 1 (100.0)
Co-morbidity
Yes 52 (19.6) 213 (80.4) 0.806
No 10 (18.2) 45 (81.8)
Complication
Yes 18 (22.2) 63 (77.8) 0.453
No 44 (18.4) 195 (81.6)
Family history of DAS
Yes 14 (87.5) 2 (12.5) 0.001
No 48 (15.8) 256 (84.2)

Table 5: Summary of the associations between DAS and the demographic variables and selected variables.

Variable Pearson chi-square (p-value)
Depression Anxiety Stress
Age (years) 3.198 8.253 6.245
(0.784) (0.220) (0.396)
Sex 3.013 3.346 1.326
(0.083) (0.067) (0.250)
Ethnicity 6.188 2.767 6.997
(0.183) (0.429) (0.072)
Religion 4.911 3.559 5.908
(0.297) (0.469) (0.206)
Marital status 8.874 7.264 6.767
(0.031) (0.054) (0.080)
Education level 3.041 2.919 0.378
(0.385) (0.404) (0.495)
Occupation 5.674 2.666 9.275
(0.129) (0.446) (0.026)*
Household income (RM) 8.079 6.909 6.931
(0.044)* (0.075) (0.074)
Smoking 0.150 0.571 1.312
(0.698) (0.450) (0.252)
HbA1c (%) 2.620 0.381 0.125
(0.106) (0.537) (0.723)
Duration of diabetes (months) 4.315 6.824 12.248
(0.505) (0.234) (0.032)*
Duration of follow-up 0.890 0.436 0.438
(1.128) (3.783) (3.823)
Diabetes treatment 0.568 0.636 0.430
(2.020) (1.703) (7.465)
Co-morbidity 0.218 4.483 0.061
(0.641) (0.034)* (0.806)
Complication 1.029 0.893 0.563
(0.310) (0.345) (0.453)
Family history of DAS 25.822 11.941 50.038
(<0.001)* (0.001)* (<0.001)*

Significant at 5% significant level

Discussion

The prevalence of DAS in our study was 26.6%, 40% and 19.4%, respectively. These were higher compared with a similar study in Klang Valley, Malaysia by Gurpreet et al. using DASS-21 assessment tool where the prevalence of DAS was 11.5%, 30.5% and 12% respectively.10

The differences in the prevalence rates of our study and Gurpreet et al. may be attributed to the demographic differences of our populations. In particular, our study was limited by a smaller number of sample size, a lower proportion of married subjects, a lower mean household income, a higher rate of unemployment and a higher rate of co-morbidity. Our study mirrored another large study in Qatar involving 12 primary healthcare centres using similar DASS-21 assessment tool,11 where the prevalence of DAS was 13.6%, 35.3% and 23.4% respectively.

The prevalence of depression in our study was more than two times higher than the prevalence of depression in the general population (10%).12 This was in keeping with a meta-analysis study by Anderson et al. with a prevalence of 11% in general population and 31% in diabetes patients.13 The depressive symptomss rate we found was also comparable to a study14 done in Bahrain (33%), although in that study, the Beck Depression Inventory (BDI) scale was used as the study instrument.

However, a study conducted by Roshana et al.15 on 260 respondents from the Diabetic Centre, Hospital USM (HUSM), found the prevalence of depression to be 12.3%. The education level of the participants and the presence of complications were identified as significant risk factors. The difference between the findings of this study and those of ours may be due to the different study instrument used by HUSM. In that study, the HADS (Hospital Anxiety and Depression Scale) was used. The study done by Roshana et al.17 involved all respondents from the tertiary care centre as compared with our study involving respondents from the primary care. Their mean HbA1c was higher (8.5 ± 1.8% vs 7.78 ± 1.7%). This indicated higher prevalence of diabetic complications in their study population.

We found the prevalence of DAS among type 2 diabetes patients at the private general practice clinics and the government community clinics were similar. The prevalence of DAS in the private general practice clinics compared with the government community clinics was as follows: 26.4% vs 23.8% for depression, 36.8% vs 41.6% for anxiety and 19.8% vs 17.3% for stress. This finding is important, as there are limited studies involving diabetes patients from the private sector in the medical literature.

Our study revealed that marital status and the family history of DAS were predictors of depression. These findings were consistent with those from the studies by Martin et al. and Agbir et al.16,17 Gurpreet et al.10 also showed a family history of psychiatric illness was the strongest predictor of DAS among patients with diabetes. We found that the respondents who were married were less likely to be depressed compared with those who were either single, separated or widowed.

Although various social factors such as age, gender, ethnicity, level of education, occupation, HbA1c level, duration of diabetes and presence of complications were cited to be associated with depression, our study failed to prove such an association. A study done by Raval et al.18 in India proved that high prevalence of depression in patients with type 2 diabetes mellitus was associated with diabetic complications particularly neuropathy and diabetic foot disease. This study was conducted on patients at a tertiary care centre, whereas our study was conducted at the primary care setting, where the prevalence of complications was likely to be much lower.

We found the prevalence of anxiety to be almost double that of depression and stress. Our findings concurred with those from other studies19,20 that anxiety is common in medical illness, supporting the association between psychiatric illness and chronic medical conditions such as diabetes.

A similar study done in Karachi showed that the prevalence of anxiety in adult patients with type 2 diabetes was 57.9%.21 This study also noted that having co-morbidities such as hypertension or ischaemic heart disease was significantly associated. The metabolic component found to be associated with anxiety was raised blood triglycerides levels.21 A descriptive, cross-sectional study22 done in a Malaysian public hospital also showed that ischaemic heart disease was significantly associated with anxiety.

Our study also found that occupation appears to be a strong predictor for stress symptoms. Patients who were working as non-professional seems appear more likely to be stressed compared with those who were working as professionals, unemployed or retired. Those who work as non-professionals may be probably stressed regarding their job stability and work life balance. They may be too busy to understand their illness and to manage their condition.

Although several factors have been identified to be associated with DAS among patients with diabetes in our study, in general, different studies have shown a vast array of factors different from our study contributing to DAS. The differences were due to the different studies being set in different cultures, demography, disease process, duration of disease and financial situations.

Our study indicated that a family history of DAS was strongly associated with positive DAS scores. This shows that taking family history of psychiatric illness is important in identifying a vulnerable group for screening and management of psychiatric illness. The high prevalence of DAS and the limited number of predictors imply that all patients with diabetes should be screened for DAS. The Canadian Diabetes Association suggested to routinely screen for depression and anxiety among patients with diabetes.23 Katon et al. and Lichtman et al. acknowledged depression as a co-morbidity of chronic diseases, such as diabetes mellitus and coronary heart disease, and which may often lead to worse clinical outcome.24,25 Korsen suggested screening for depression in patients with chronic diseases.26

In view of the high prevalence of DAS in patients with diabetes mellitus and a family history of DAS being a strong predictor, we recommend that patients with diabetes mellitus be routinely screened for symptoms of DAS.

For better representation and associations, we also recommend that future studies should be done involving a larger number of samples from multiple centres and patient selection should be done in a more systematic manner.

Conclusions

Our study showed that the prevalence of DAS is high in patients with type 2 diabetes mellitus: 26.6% (depressing), 40% (anxiety) and 19.4% (stress), The strongest association was found to be a positive family history of DAS. Yet, only 5% of the study population was found to have a family history. Hence, our recommendation is to screen all type 2 diabetes patients using DASS-21 routinely because it is simple, easy to perform and inexpensive.

How does this paper make a difference? depression, anxiety and stress

  • Common psychiatric disorders such as exist in chronic diseases, especially diabetes mellitus

  • This paper highlights the prevalence of these disorders in patients with diabetes mellitus

  • It emphasises the need to screen for these psychiatric disorders while managing patients with diabetes mellitus

Footnotes

Tan KC, Chan GC, Eric H, Maria AI, Norliza MJ, Oun BH, Sheerine MT, Wong SJ, Liew SM. Depression, anxiety and stress among patients with diabetes in primary care: A cross-sectional study.Malays Fam Physician. 2015;10(2):9-21.

References

  • 1.Wild S, Roglic G, Sicree R. et al. Global prevalence of diabetes. Diabetes Care. 2004;25(5):1047–53. doi: 10.2337/diacare.27.5.1047. [DOI] [PubMed] [Google Scholar]
  • 2.Institute of Public Health. National health and morbidity survey 2011 (NHMS 2011). Noncommunicable diseases. Kuala Lumpur: Institute for Public Health (IPH); 2011. [Google Scholar]
  • 3.Gabriel O Ivbijaro. Mental health and chronic physical illnesses: The need for continued and intergrated care. Vancouver: World Federation for Mental Health; 2010. [Google Scholar]
  • 4.Zhang X, Norris SL, Gregg EW. et al. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005 Apr 1;161(7):652–60. doi: 10.1093/aje/kwi089. [DOI] [PubMed] [Google Scholar]
  • 5.IDF Clinical Guidelines Task Force. Global guideline for type 2 diabetes. Brussels: International Diabetes Federation; 2005. [Google Scholar]
  • 6.World Health Organization. WHO: Noncommunicable diseases. Available from http://www.euro.who.int/en/health-topics/ noncommunicable-diseases/pages/news/ news/2012/10/depression-in-europe/ depression-definition/ Assessed May 25, 2015.
  • 7.Oxford dictionary. London: Oxford University Press; 2015. Available from: http://www.oxforddictionaries.com/ Accessed May 25, 2015. [Google Scholar]
  • 8.Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes: An epidemiological evaluation. Diabetes Care. 1993;16:1167–78. doi: 10.2337/diacare.16.8.1167. [DOI] [PubMed] [Google Scholar]
  • 9.Lovibond SH, Lovibond PF. Manual for the depression anxiety stress scales. Sydney: Psychology Foundation; 1995. [Google Scholar]
  • 10.Gurpreet K, Tee GH, Suthahar A. et al. Depression, anxiety and stress symptoms among diabetics in Malaysia: A cross sectional study in an urban primary care setting. BMC Fam Pract. 2013;14:69. doi: 10.1186/1471-2296-14-69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Abdulbari B, Abdulla OAAA, Elnour ED. High prevalence of depression, anxiety and stress symptoms among diabetes mellitus patients. The Open Psychiatry Journal. 2011;5:5–12. [Google Scholar]
  • 12.Gonzalez O, Berry JT, McKnight-Eily LR. et al. Morbidity and mortality report: Current depression among adults in Unites States 2006 and 2008. MMWR. 2010;59(38):1229–35. [PubMed] [Google Scholar]
  • 13.Ryan JA, Kenneth EF, Ray EC. et al. The prevalence of co-morbid depression in adults with diabetes-a meta-analysis. Diabetes Care. 2001;24(6):1069–78. doi: 10.2337/diacare.24.6.1069. [DOI] [PubMed] [Google Scholar]
  • 14.Jmeel N, Fatima H, Majeda H. et al. Prevalence of depression among people with diabetes attending diabetes clinics at primary health setting. Bahrain Med Bull. 2009;31(3) [Google Scholar]
  • 15.Roshana M, Azidah AK, Lili HY. A study on depression among patient with type 2 diabetes mellitus in north-east coast Malaysia. Int J Collab Res Intern Med Public Health. 2012;4(8):1589–1600. [Google Scholar]
  • 16.Martin L, Maria R. Marital status, social capital, economic stress, and mental health: A population-based study. Soc Sci J. 2012;49(3):339–42. [Google Scholar]
  • 17.Agbir TM, Audu MD, Adebowale TO. et al. Depression among medical outpatients with diabetes: A cross-sectional study at Jos University Teaching Hospital, Jos, Nigeria. Ann Afr Med. 2010;9(1):5–10. doi: 10.4103/1596-3519.62617. [DOI] [PubMed] [Google Scholar]
  • 18.Raval A, Dhanaraj E, Bhansali A. et al. Prevalence and determinants of depression in type 2 diabetes patients in a tertiary care centre. Indian J Med Res. 2010;132:195–200. [PubMed] [Google Scholar]
  • 19.Stein MB, Cox BJ, Afifi TO. et al. Does comorbid depressive illness magnify the impact of chronic physical illness? A population-based perspective. Psychol Med. 2006;36(5):587–96. doi: 10.1017/S0033291706007239. [DOI] [PubMed] [Google Scholar]
  • 20.Lin EH, Katon W, Von Korff M. et al. Relationship of depression and diabetes selfcare, medication adherence, and preventive care. Diabetes Care. 2004;27(9):2154–60. doi: 10.2337/diacare.27.9.2154. [DOI] [PubMed] [Google Scholar]
  • 21.Khuwaja AK, Lalani S, Dhanani R. et al. Anxiety and depression among outpatients with type 2 diabetes: A multi-centre study of prevalence and associated factors. Diabetol Metab Syndr. 2010;2:72. doi: 10.1186/1758-5996-2-72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kurubaran G, Pukunan R, Rizal AM. et al. Factors associated with anxiety and depression among type 2 diabetes outpatients in Malaysia: A descriptive cross-sectional single-centre study. BMJ Open. 2014;(4) doi: 10.1136/bmjopen-2014-004794. e004794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Robinson DJ, Luthra M, Vallis M. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada: Diabetes and mental health. Can J Diabetes. 2013;(suppl 1):S87–S92. doi: 10.1016/j.jcjd.2013.01.026. [DOI] [PubMed] [Google Scholar]
  • 24.Katon WJ, Russo JE, Von Korff M. et al. Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes. Diabetes Care. 2008;31(6):1155–9. doi: 10.2337/dc08-0032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lichtman JH, Bigger JT Jr, Blumenthal JA. et al. American Heart Association Prevention Committee of the Council on Cardiovascular Nursing; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention; American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research; American Psychiatric Association. Circulation. 2008;118(17):1768–75. doi: 10.1161/CIRCULATIONAHA.108.190769. [DOI] [PubMed] [Google Scholar]
  • 26.Korsen N. Translating a guideline into practice: The USPSTF recommendations on screening for depression in adults. Am Fam Physician. 2010;82(8):891. [PubMed] [Google Scholar]

Articles from Malaysian Family Physician : the Official Journal of the Academy of Family Physicians of Malaysia are provided here courtesy of Academy of Family Physicians of Malaysia

RESOURCES